O SlideShare utiliza cookies para otimizar a funcionalidade e o desempenho do site, assim como para apresentar publicidade mais relevante aos nossos usuários. Se você continuar a navegar o site, você aceita o uso de cookies. Leia nosso Contrato do Usuário e nossa Política de Privacidade.
O SlideShare utiliza cookies para otimizar a funcionalidade e o desempenho do site, assim como para apresentar publicidade mais relevante aos nossos usuários. Se você continuar a utilizar o site, você aceita o uso de cookies. Leia nossa Política de Privacidade e nosso Contrato do Usuário para obter mais detalhes.
The US pharmaceutical market is forecast to increase from an estimated value of $395.2 billion in 2014 to reach $548.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.6%, according to new report. See more at- http://mrr.cm/4fL
Healthcare, Regulatory and Reimbursement Landscape - US
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
Introduction to Report
Launch Date: February 18, 2015
Number of Pages: 292
Geography Coverage: USA
Available Format: PDF
Price For Single User License: USD 1,995
Price For Site User License: USD 3,990
Price For Global User License: USD 5,985
Delivery Time: Within 24 Hours (During Working Days)
About the Report
CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape US report is an essential
source of information on and analysis of the healthcare,
regulatory and reimbursement landscape in the US.
It identifies key trends in the country’s healthcare market
and provides insights into its demographic, regulatory,
and reimbursement landscape and healthcare
infrastructure. Most importantly, the report provides
valuable insights into the trends and segmentation of its
pharmaceutical and medical devices markets.
The population of the US in 2013 amounted to 316.1
million, having grown at a Compound Annual Growth
Rate (CAGR) of 0.8% from 2008.
The country’s increasingly elderly population and
corresponding increase in the incidence of chronic
diseases will help to boost the growth of the
pharmaceutical market, which was worth $326.9 billion in
2008, a value that is expected to have reached $548.4
billion by 2020 at a CAGR of 4.4%.
Approximately 86.6% of the US population has
healthcare coverage, which has helped to create an
efficient healthcare system.
Key Highlights Continues…
New initiatives taken by the Food and Drug
Administration (FDA) have strengthened the review and
The value of the US medical device market was $116.2
billion in 2008, and is expected to register a CAGR of 5.0%
to reach an estimated $209.7 billion in 2020.
An overview of the pharmaceutical and medical device
markets, including market size, segmentation, and key
drivers and barriers
Insightful review of the reimbursement and regulatory
landscape, with analysis covering details of the country’s
healthcare reimbursement process, regulatory agencies
and the approval processes for new drugs and medical
Detailed analysis of the political and economic
environment, covering economic indicators,
demographics, healthcare infrastructure and healthcare
An overview of the opportunities for and challenges to
growth in the healthcare market
2. Overview of Pharmaceutical and Medical Device
3. Market Access
4. Country Analysis
5. Opportunities and Challenges
For more details regarding Report coverage see the last slide
Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
For Any Customization Related query Visit IdeaCenter @
For regular industry updates subscribe to our newsletter
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : firstname.lastname@example.org
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)